T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Apple
AAPL
|
+$2.86B |
| 2 |
Merck
MRK
|
+$864M |
| 3 |
Electronic Arts
EA
|
+$827M |
| 4 |
FRC
First Republic Bank
FRC
|
+$710M |
| 5 |
Equifax
EFX
|
+$705M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.34B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.26B |
| 3 |
AET
Aetna Inc
AET
|
+$904M |
| 4 |
FedEx
FDX
|
+$799M |
| 5 |
GE Aerospace
GE
|
+$795M |
Sector Composition
| 1 | Healthcare | 17.33% |
| 2 | Financials | 16.18% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Technology | 13.89% |
| 5 | Communication Services | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Cognizant
CTSH
$33.8B
| $147M | 0.03% |
2,471,734
-64,361
| -3% | -$3.83M |
|
502
Infosys
INFY
$70.4B
| $147M | 0.03% |
18,602,718
+2,475,520
| +15% | +$19.6M |
|
503
CSX Corp
CSX
$59.8B
| $146M | 0.03% |
9,429,741
+3,483,456
| +59% | +$54.1M |
|
504
Cintas
CTAS
$81.2B
| $145M | 0.03% |
4,585,336
-88,548
| -2% | -$2.8M |
|
505
CyberArk
CYBR
$23.6B
| $145M | 0.03% |
2,844,326
-659,560
| -19% | -$33.6M |
|
506
Haemonetics
HAE
$2.59B
| $141M | 0.03% |
3,470,891
-1,931,040
| -36% | -$78.3M |
|
507
RE/MAX Holdings
RMAX
$187M
| $140M | 0.03% |
2,360,742
-19,300
| -0.8% | -$1.15M |
|
|
KTWO
508
DELISTED
K2M Group Holdings, Inc
KTWO
| $138M | 0.03% |
6,729,420
+538,411
| +9% | +$11M |
|
509
Invesco
IVZ
$9.88B
| $137M | 0.03% |
4,485,423
-397,379
| -8% | -$12.2M |
|
|
UNVR
510
DELISTED
Univar Solutions Inc.
UNVR
| $137M | 0.03% |
4,465,582
+308,157
| +7% | +$9.45M |
|
511
DaVita
DVA
$9.46B
| $137M | 0.03% |
2,011,951
-724,740
| -26% | -$49.3M |
|
|
TCO
512
DELISTED
Taubman Centers Inc.
TCO
| $136M | 0.03% |
2,064,235
+322,812
| +19% | +$21.3M |
|
513
Align Technology
ALGN
$9.64B
| $136M | 0.03% |
1,186,114
-121,985
| -9% | -$14M |
|
514
Ecolab
ECL
$76.3B
| $136M | 0.03% |
1,083,064
-86,650
| -7% | -$10.9M |
|
515
Westamerica Bancorp
WABC
$1.25B
| $135M | 0.03% |
2,425,351
+232,023
| +11% | +$13M |
|
516
First American
FAF
$6.74B
| $134M | 0.03% |
3,418,437
+54,146
| +2% | +$2.13M |
|
517
Expro
XPRO
$1.42B
| $133M | 0.03% |
2,101,717
+1,276,214
| +155% | +$80.9M |
|
518
DuPont de Nemours
DD
$31.9B
| $133M | 0.03% |
1,039,762
-19,362
| -2% | -$2.48M |
|
519
Belden
BDC
$5.15B
| $133M | 0.03% |
1,926,184
-17,335
| -0.9% | -$1.2M |
|
520
TIM SA
TIMB
$10B
| $133M | 0.02% |
8,332,043
-1,430,963
| -15% | -$22.9M |
|
521
Brown & Brown
BRO
$30.5B
| $132M | 0.02% |
6,319,736
+299,626
| +5% | +$6.25M |
|
522
TripAdvisor
TRIP
$2.06B
| $131M | 0.02% |
3,034,512
+35,346
| +1% | +$1.53M |
|
523
Scholastic
SCHL
$660M
| $131M | 0.02% |
3,069,368
-254,912
| -8% | -$10.9M |
|
524
BioMarin Pharmaceuticals
BMRN
$10.5B
| $131M | 0.02% |
1,486,731
+295,308
| +25% | +$25.9M |
|
525
Micron Technology
MU
$157B
| $130M | 0.02% |
4,504,575
-2,062,633
| -31% | -$59.6M |
|